Search Within

Alexander Noor Shoushtari

  1. "GSK Faculty"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (31)
  3. Research Letter (6)
  4. Review (2)
Groups
  1. Department of Medicine (86)
  2. GSK Faculty (86)
  3. Hematologic Malignancies, Division of (86)
  4. Melanoma Disease Management Team (86)
  5. Melanoma and Immunotherapeutics Service (86)
  6. Solid Tumor Oncology Division (86)

More Groups

People
  1. Jedd Wolchok (49)
  2. Michael Postow (49)
  3. Paul Chapman (40)
  4. Margaret Callahan (37)
  5. Katherine Panageas (28)
  6. Parisa Momtaz (25)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (9)
  4. 2022 (9)
  5. 2021 (13)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (24)
  2. Clinical Cancer Research (7)
  3. Journal for ImmunoTherapy of Cancer (5)
  4. Nature Genetics (4)
  5. The Oncologist (4)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. American Association for Cancer Research (11)
  3. Nature Publishing Group (9)
  4. Oxford University Press (6)
  5. Biomed Central Ltd (5)
  6. American Medical Association (4)

More Publishers

Results (86)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB)
    Meeting Abstract

    Loo, K.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Association of plasma circulating tumor DNA with diagnosis of metastatic uveal melanoma
    Research Letter

    Francis, J. H.; Canestraro, J.; Brannon, A. R.; Barker, C. A.; Berger, M.; Shoushtari, A. N.; Abramson, D. H.
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab (pembro) in checkpoint inhibitor refractory advanced or unresectable melanoma
    Meeting Abstract

    Shoushtari, A. N.; Olszanski, A. J.; Nyakas, M.; Hornyak, T. J.; Wolchok, J. D.; Levitsky, V.; Møller, A. S.; Kuryk, L.; Handeland, K. R.; Jäderberg, M.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
    Journal Article

    Shen, R.; Postow, M. A.; Adamow, M.; Arora, A.; Hannum, M.; Maher, C.; Wong, P.; Curran, M. A.; Hollmann, T. J.; Jia, L.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression
    Journal Article

    Bakhoum, M. F.; Francis, J. H.; Agustinus, A.; Earlie, E. M.; Di Bona, M.; Abramson, D. H.; Duran, M.; Masilionis, I.; Molina, E.; Shoushtari, A. N.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Metastasis and immune evasion from extracellular cGAMP hydrolysis
    Journal Article

    Li, J.; Duran, M. A.; Dhanota, N.; Chatila, W. K.; Bettigole, S. E.; Kwon, J.; Sriram, R. K.; Humphries, M. P.; Salto-Tellez, M.; James, J. A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Combined inhibition of Gα(q) and MEK enhances therapeutic efficacy in uveal melanoma
    Journal Article

    Hitchman, T. D.; Bayshtok, G.; Ceraudo, E.; Moore, A. R.; Lee, C.; Jia, R.; Wang, N.; Pachai, M. R.; Shoushtari, A. N.; Francis, J. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save